Skip to main content

Advertisement

Springer Nature Link
Log in

Impact of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio on 5-Year Clinical Outcomes of Patients with Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention

  • Original Article
  • Published:
Journal of Cardiovascular Translational Research Aims and scope Submit manuscript

Abstract

The prognostic role of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in patients with stable coronary artery disease (CAD) is still unclear. We enrolled 500 patients undergoing elective percutaneous coronary intervention (PCI). Blood samples were drawn prior to PCI for NLR and PLR calculation. Major adverse clinical events (MACE), which included death, myocardial infarction (MI), and target vessel revascularization (TVR), were recorded up to 5 years. Patients in the higher tertile of NLR presented higher Kaplan–Meier estimates of MACE (26.0% vs. 16.9% in tertile 2 vs. 14.3% in tertile 1; p = 0.042) and death (12.0% vs 6.9% in tertile 2 vs. 4.6% in tertile 1; p = 0.040), whereas there were no significant differences in the estimates of MI and TVR. NLR in the higher tertile was an independent predictor of MACE (HR 1.65, 95% CI 1.07–2.55, p = 0.024). No significant difference was observed across tertiles of PLR. Unlike PLR, elevated pre-procedural NLR is associated with an increased risk of 5-year clinical adverse events.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ross, R. (1999). Atherosclerosis—an inflammatory disease. The New England Journal of Medicine, 340(2), 115–126.

    Article  CAS  Google Scholar 

  2. Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., Kastelein, J. J. P., Cornel, J. H., Pais, P., Pella, D., Genest, J., Cifkova, R., Lorenzatti, A., Forster, T., Kobalava, Z., Vida-Simiti, L., Flather, M., Shimokawa, H., Ogawa, H., Dellborg, M., Rossi, P. R. F., Troquay, R. P. T., Libby, P., Glynn, R. J., & CANTOS Trial Group. (2017). Antiinflammatory therapy with canakinumab for atherosclerotic disease. The New England Journal of Medicine, 377(12), 1119–1131.

    Article  CAS  Google Scholar 

  3. Davì, G., & Patrono, C. (2007). Platelet activation and atherothrombosis. The New England Journal of Medicine, 357(24), 2482–2494.

    Article  Google Scholar 

  4. Mangiacapra, F., & Barbato, E. (2013). Clinical implications of platelet-vessel interaction. Journal of Cardiovascular Translational Research, 6(3), 310–315.

    Article  Google Scholar 

  5. Sabatine, M. S., Morrow, D. A., Cannon, C. P., Murphy, S. A., Demopoulos, L. A., et al. (2002). Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy—Thrombolysis in Myocardial Infarction 18 trial) substudy. Journal of the American College of Cardiology, 40, 1761–1768.

    Article  Google Scholar 

  6. Onsrud, M., & Thorsby, E. (1981). Influence of in vivo hydrocortisone on some human blood lymphocyte subpopulations. I. Effect on natural killer cell activity. Scandinavian Journal of Immunology, 13, 573–579.

    Article  CAS  Google Scholar 

  7. Bressi, E., Mangiacapra, F., Ricottini, E., Cavallari, I., Colaiori, I., Di Gioia, G., Creta, A., & Di Sciascio, G. (2016). Relation of neutrophil to lymphocyte ratio with periprocedural myocardial damage in patients undergoing elective percutaneous coronary intervention. The American Journal of Cardiology, 118(7), 980–984.

    Article  Google Scholar 

  8. Cho, K. I., Ann, S. H., Singh, G. B., Her, A. Y., & Shin, E. S. (2015). Combined usefulness of the platelet-to-lymphocyte ratio and the neutrophil-to-lymphocyte ratio in predicting the long-term adverse events in patients who have undergone percutaneous coronary intervention with a drug-eluting stent. PLoS One, 10(7), e0133934.

    Article  Google Scholar 

  9. Park, J. J., Jang, H. J., Oh, I. Y., Yoon, C. H., Suh, J. W., et al. (2013). Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. The American Journal of Cardiology, 111, 636–642.

    Article  Google Scholar 

  10. White, H., Thygesen, K., Alpert, J. S., & Jaffe, A. (2014). Universal MI definition update for cardiovascular disease. Current Cardiology Reports, 16(6), 492.

    Article  Google Scholar 

  11. Cutlip, D. E., Windecker, S., Mehran, R., Boam, A., Cohen, D. J., van Es, G. A., et al. (2007). Clinical end points in coronary stent trials: a case for standardized definitions. Circulation, 115, 2344–2351.

    Article  Google Scholar 

  12. Hicks, K. A., Tcheng, J. E., Bozkurt, B., Chaitman, B. R., Cutlip, D. E., Farb, A., Fonarow, G. C., Jacobs, J. P., Jaff, M. R., Lichtman, J. H., Limacher, M. C., Mahaffey, K. W., Mehran, R., Nissen, S. E., Smith, E. E., & Targum, S. L. (2015). 2014 ACC/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). Journal of the American College of Cardiology, 66(4), 403–469.

    Article  Google Scholar 

  13. Van Tassell, B. W., Toldo, S., Mezzaroma, E., & Abbate, A. (2013). Targeting interleukin-1 in heart disease. Circulation, 128(17), 1910–1923.

    Article  Google Scholar 

  14. Hotchkiss, R. S., & Karl, I. E. (2003). The pathophysiology and treatment of sepsis. The New England Journal of Medicine, 348, 138–150.

    Article  CAS  Google Scholar 

  15. Kaya, M. G., Akpek, M., Lam, Y. Y., Yarlioglues, M., Celik, T., et al. (2013). Prognostic value of neutrophil/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: a prospective, multicenter study. International Journal of Cardiology, 168, 1154–1159.

    Article  Google Scholar 

  16. Wang, X., Zhang, G., Jiang, X., Zhu, H., Lu, Z., & Xu, L. (2014). Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: a meta-analysis of observational studies. Atherosclerosis, 234, 206–213.

    Article  CAS  Google Scholar 

  17. Wada, H., Dohi, T., Miyauchi, K., Shitara, J., Endo, H., Doi, S., Konishi, H., Naito, R., Tsuboi, S., Ogita, M., Kasai, T., Hassan, A., Okazaki, S., Isoda, K., Suwa, S., & Daida, H. (2017). Pre-procedural neutrophil-to-lymphocyte ratio and long-term cardiac outcomes after percutaneous coronary intervention for stable coronary artery disease. Atherosclerosis, 265, 35–40.

    Article  CAS  Google Scholar 

  18. Muller, O., Hamilos, M., Bartunek, J., Ulrichts, H., Mangiacapra, F., Holz, J. B., Ntalianis, A., Trana, C., Dierickx, K., Vercruysse, K., De Bruyne, B., Wijns, W., & Barbato, E. (2010). Relation of endothelial function to residual platelet reactivity after clopidogrel in patients with stable angina pectoris undergoing percutaneous coronary intervention. The American Journal of Cardiology, 105(3), 333–338.

    Article  CAS  Google Scholar 

  19. Mangiacapra, F., Bartunek, J., Bijnens, N., Peace, A. J., Dierickx, K., Bailleul, E., Di Serafino, L., Pyxaras, S. A., Fraeyman, A., Meeus, P., Rutten, M., De Bruyne, B., Wijns, W., van de Vosse, F., & Barbato, E. (2012). Periprocedural variations of platelet reactivity during elective percutaneous coronary intervention. Journal of Thrombosis and Haemostasis, 10(12), 2452–2461.

    Article  CAS  Google Scholar 

  20. Mangiacapra, F., Colaiori, I., Ricottini, E., Creta, A., Di Gioia, G., Cavallari, I., Bressi, E., Capuano, M., Barbato, E., & Di Sciascio, G. (2018). Impact of platelet reactivity on 5-year clinical outcomes following percutaneous coronary intervention: a landmark analysis. Journal of Thrombosis and Thrombolysis, 45(4), 496–503.

    Article  Google Scholar 

  21. Leader, A., Pereg, D., & Lishner, M. (2012). Are platelet volume indices of clinical use? A multidisciplinary review. Annals of Medicine, 44(8), 805–816.

    Article  Google Scholar 

  22. Ricottini, E., Mangiacapra, F., Nusca, A., Melfi, R., Cavallari, I., Miglionico, M., Gallo, P., Pozzilli, P., & Di Sciascio, G. (2018). Relation of platelet indexes to platelet reactivity and periprocedural myocardial infarction in patients who underwent percutaneous coronary angioplasty. The American Journal of Cardiology, 121(9), 1027–1031.

    Article  Google Scholar 

  23. Lee, Y. S. G., Baradi, A., Peverelle, M., Sultani, R., Adams, H., Garlick, J., & Wilson, A. M. (2018). Usefulness of platelet-to-lymphocyte ratio to predict long-term all-cause mortality in patients at high risk of coronary artery disease who underwent coronary angiography. The American Journal of Cardiology, 121(9), 1021–1026.

    Article  Google Scholar 

  24. Li, H., Zhou, Y., Ma, Y., Han, S., & Zhou, L. (2017). The prognostic value of the platelet-to lymphocyte ratio in acute coronary syndrome: a systematic review and meta-analysis. Kardiologia Polska, 75(7), 666–673.

    Article  Google Scholar 

  25. Olędzki, S., Kornacewicz-Jach, Z., Safranow, K., Kiedrowicz, R., Gawrońska-Szklarz, B., Jastrzębska, M., & Gorący, J. (2017). Variability of platelet response to clopidogrel is not related to adverse cardiovascular events in patients with stable coronary artery disease undergoing percutaneous coronary intervention. European Journal of Clinical Pharmacology, 73(9), 1085–1094.

    Article  Google Scholar 

  26. Erhart, S., Beer, J. H., & Reinhart, W. H. (1999). Influence of aspirin on platelet count and volume in humans. Acta Haematologica, 101(3), 140–144.

    Article  CAS  Google Scholar 

  27. Tonyali, S., Ceylan, C., Yahsi, S., & Karakan, M. S. (2018). Does neutrophil to lymphocyte ratio demonstrate deterioration in renal function? Renal Failure, 40(1), 209–212.

    Article  Google Scholar 

  28. Neuen, B. L., Leather, N., Greenwood, A. M., Gunnarsson, R., Cho, Y., & Mantha, M. L. (2016). Neutrophil-lymphocyte ratio predicts cardiovascular and all-cause mortality in hemodialysis patients. Renal Failure, 38(1), 70–76.

    Article  Google Scholar 

  29. Seropian, I. M., Romeo, F. J., Pizarro, R., Vulcano, N. O., Posatini, R. A., Marenchino, R. G., Berrocal, D. H., & Belziti, C. A. (2018). Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as predictors of survival after heart transplantation. ESC Heart Fail., 5(1), 149–156.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiovascular Sciences, Campus Bio-Medico University of Rome, Via Álvaro del Portillo, 200, 00128, Rome, Italy

    Edoardo Bressi, Fabio Mangiacapra, Elisabetta Ricottini, Ilaria Cavallari, Iginio Colaiori, Giuseppe Di Gioia, Antonio Creta, Marialessia Capuano, Michele Mattia Viscusi & Germano Di Sciascio

Authors
  1. Edoardo Bressi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fabio Mangiacapra
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elisabetta Ricottini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ilaria Cavallari
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Iginio Colaiori
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Giuseppe Di Gioia
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Antonio Creta
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Marialessia Capuano
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Michele Mattia Viscusi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Germano Di Sciascio
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fabio Mangiacapra.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Associate Editor Craig Stolen oversaw the review of this article

Key Messages

The results of our study suggest that neutrophil-to-lymphocyte ratio (NLR), a simple and easily available inflammatory marker, may be used for risk stratification of patients undergoing elective percutaneous coronary revascularization, in that elevated pre-procedural values of NLR may help identify those patients at higher risk of future clinical adverse events. These patients may potentially benefit from tailored therapeutic strategies, such as more aggressive anti-inflammatory and anti-thrombotic treatment. This hypothesis warrants further investigation.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bressi, E., Mangiacapra, F., Ricottini, E. et al. Impact of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio on 5-Year Clinical Outcomes of Patients with Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention. J. of Cardiovasc. Trans. Res. 11, 517–523 (2018). https://doi.org/10.1007/s12265-018-9829-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12265-018-9829-6

Keywords

Search

Navigation